Daxor EBITDA Margin 2010-2011 | DXR

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Daxor (DXR) over the last 10 years. The current EBITDA margin for Daxor as of December 31, 2011 is .
Daxor EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2011-12-31 $0.00B $-0.01B 0.00%
2011-09-30 $0.00B $-0.01B 0.00%
2011-06-30 $0.00B $-0.01B 0.00%
2011-03-31 $0.00B $-0.01B 0.00%
2010-12-31 $0.00B $0.00B 0.00%
2010-09-30 $0.00B $0.00B 0.00%
2010-06-30 $0.00B $0.00B 0.00%
2010-03-31 $0.00B $0.00B 0.00%
2009-12-31 $0.00B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.042B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.118B 19.83
Encompass Health (EHC) United States $12.188B 25.84
DaVita (DVA) United States $10.277B 14.45
Chemed (CHE) United States $8.063B 25.34
Elanco Animal Health (ELAN) United States $6.859B 14.69
Option Care Health (OPCH) United States $5.174B 23.07
RadNet (RDNT) United States $4.157B 263.86
Amedisys (AMED) United States $3.189B 21.45
Addus HomeCare (ADUS) United States $2.075B 22.79
LifeStance Health (LFST) United States $2.045B 0.00
Astrana Health (ASTH) United States $1.444B 35.76
U.S Physical Therapy (USPH) United States $1.170B 30.20
Aveanna Healthcare Holdings (AVAH) United States $0.958B 54.56
Pennant (PNTG) United States $0.954B 35.03
Atai Life Sciences (ATAI) Germany $0.423B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.044B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00